Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305;
Ludwig Center for Cancer Stem Cell Research and Medicine, Stanford University School of Medicine, Stanford, CA 94305.
Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9308-E9316. doi: 10.1073/pnas.1805434115. Epub 2018 Aug 27.
Different combinations of transcription factors (TFs) function at each stage of hematopoiesis, leading to distinct expression patterns of lineage-specific genes. The identification of such regulators and their functions in hematopoiesis remain largely unresolved. In this study, we utilized screening approaches to study the transcriptional regulators of megakaryocyte progenitor (MkP) generation, a key step before platelet production. Promising candidate genes were generated from a microarray platform gene expression commons and individually manipulated in human hematopoietic stem and progenitor cells (HSPCs). Deletion of some of the candidate genes (the hit genes) by CRISPR/Cas9 led to decreased MkP generation during HSPC differentiation, while more MkPs were produced when some hit genes were overexpressed in HSPCs. We then demonstrated that overexpression of these genes can increase the frequency of mature megakaryocytic colonies by functional colony forming unit-megakaryocyte (CFU-Mk) assay and the release of platelets after in vitro maturation. Finally, we showed that the histone deacetylase inhibitors could also increase MkP differentiation, possibly by regulating some of the newly identified TFs. Therefore, identification of such regulators will advance the understanding of basic mechanisms of HSPC differentiation and conceivably enable the generation and maturation of megakaryocytes and platelets in vitro.
不同组合的转录因子(TFs)在造血的每个阶段发挥作用,导致谱系特异性基因的不同表达模式。这些调节因子的鉴定及其在造血中的功能在很大程度上仍未得到解决。在这项研究中,我们利用筛选方法研究巨核细胞祖细胞(MkP)生成的转录调节因子,这是血小板生成前的关键步骤。从微阵列平台基因表达公共数据库中生成有前途的候选基因,并在人类造血干细胞和祖细胞(HSPCs)中单独操纵这些基因。CRISPR/Cas9 敲除一些候选基因(命中基因)会导致 HSPC 分化过程中 MkP 生成减少,而当一些命中基因在 HSPC 中过表达时,会产生更多的 MkP。然后,我们证明这些基因的过表达可以通过功能集落形成单位-巨核细胞(CFU-Mk)测定和体外成熟后血小板的释放来增加成熟巨核细胞集落的频率。最后,我们表明组蛋白去乙酰化酶抑制剂也可以增加 MkP 分化,可能是通过调节一些新鉴定的 TF。因此,此类调节剂的鉴定将推进对 HSPC 分化基本机制的理解,并可以设想在体外生成和成熟巨核细胞和血小板。